Granisetron Hydrochloride

ANDA 78880, held by Bionpharma. Granisetron Hydrochloride.

As of Nov 15, 2026, ANDA 78880 (Granisetron Hydrochloride), held by Bionpharma, was first approved by FDA on Jun 30, 2008, with 1 approved supplement and 0 published complete response letters.

First approved: Jun 30, 2008
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Jun 30, 2008	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Granisetron HydrochlorideEQ 4MG BASE/4ML (EQ 1MG BASE/ML) · injectable;injection	Granisetron Hydrochloride	Rx

All 2 submissions, including labeling and manufacturing supplements


Sep 18, 2014	Supplement 1Labeling · Standard review	Approved	None posted
Jun 30, 2008	Original application	Approved	None posted

Identifiers

Application: ANDA 78880
Drugs@FDA: Overview at FDA
Company: Bionpharma

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters